Fecal microbiota transplantation therapy in Crohn's disease: Systematic review

The gastrointestinal microbiota is the key antigenic drive in the inflammatory bowel diseases. Randomized controlled trials (RCTs) in ulcerative colitis have established fecal microbiota transplantation (FMT) as an effective therapy. We have conducted a systematic review to evaluate the efficacy of FMT in Crohn's disease.A systematic literature search was performed through to August 2020 (MEDLINE; Embase). Studies were included if they reported...